Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops and commercializes therapeutics. The Company sells and distributes Truvada, Viread, Emtriva, Hepsera and AmBisome in Asia, Australia, Europe, Latin America, the Middle East and New Zealand, through its commercial teams, third party distributors or partners.